• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向结核分枝杆菌 FadD23 的潜在抑制剂的结构基础。

Structural basis for the development of potential inhibitors targeting FadD23 from Mycobacterium tuberculosis.

机构信息

State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for Cell Responses, College of Life Sciences, Nankai University, Tianjin, People's Republic of China.

College of Pharmacy, Nankai University, Tianjin, People's Republic of China.

出版信息

Acta Crystallogr F Struct Biol Commun. 2023 Aug 1;79(Pt 8):208-216. doi: 10.1107/S2053230X23005836. Epub 2023 Jul 31.

DOI:10.1107/S2053230X23005836
PMID:37522751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10416763/
Abstract

Sulfolipid-1 (SL-1) is a lipid that is abundantly found in the cell wall of Mycobacterium tuberculosis (Mtb). MtbFadD23 is crucial in the SL-1 synthesis pathway. Previously, 5'-O-[N-(11-phenoxyundecanoyl)sulfamoyl]adenosine (PhU-AMS) has been shown to be a general inhibitor of fatty-acid-adenylating enzymes (FadDs) in Mtb. However, the fatty acyl-AMP ligase (FAAL) class of FadDs, which includes MtbFadD23, appears to be functionally nonredundant in the production of multiple fatty acids. In this study, the ability of PhU-AMS to bind to MtbFadD23 was examined under in vitro conditions. The crystal structure of the MtbFadD23-PhU-AMS complex was determined at a resolution of 2.64 Å. Novel features were identified by structural analysis and comparison. Although PhU-AMS could bind to MtbFadD23, it did not inhibit the FAAL adenylation activity of MtbFadD23. However, PhU-AMS improved the main T value in a differential scanning fluorimetry assay, and a structural comparison of MtbFadD23-PhU-AMS with FadD32 and PA1221 suggested that PhU-AMS blocks the loading of the acyl chain onto Pks2. This study sheds light on the structure-based design of specific inhibitors of MtbFadD23 and general inhibitors of FAALs.

摘要

硫脂-1(SL-1)是一种大量存在于结核分枝杆菌(Mtb)细胞壁中的脂质。MtbFadD23 在 SL-1 合成途径中至关重要。先前,5'-O-[N-(11-苯氧基十一烷酰基)磺酰胺基]腺苷(PhU-AMS)已被证明是 Mtb 中脂肪酸腺苷酸化酶(FadDs)的通用抑制剂。然而,包括 MtbFadD23 在内的脂肪酸酰基-AMP 连接酶(FAAL)类 FadDs 在多种脂肪酸的产生中似乎具有功能上的非冗余性。在这项研究中,在体外条件下检查了 PhU-AMS 与 MtbFadD23 结合的能力。MtbFadD23-PhU-AMS 复合物的晶体结构在 2.64 Å 的分辨率下确定。通过结构分析和比较确定了新的特征。尽管 PhU-AMS 可以与 MtbFadD23 结合,但它不能抑制 MtbFadD23 的 FAAL 腺苷酸化活性。然而,PhU-AMS 提高了差示扫描荧光法测定中的主要 T 值,并且 MtbFadD23-PhU-AMS 与 FadD32 和 PA1221 的结构比较表明 PhU-AMS 阻止了酰基链加载到 Pks2 上。这项研究为 MtbFadD23 的基于结构的特异性抑制剂和 FAALs 的通用抑制剂的设计提供了思路。

相似文献

1
Structural basis for the development of potential inhibitors targeting FadD23 from Mycobacterium tuberculosis.靶向结核分枝杆菌 FadD23 的潜在抑制剂的结构基础。
Acta Crystallogr F Struct Biol Commun. 2023 Aug 1;79(Pt 8):208-216. doi: 10.1107/S2053230X23005836. Epub 2023 Jul 31.
2
Development of small-molecule inhibitors of fatty acyl-AMP and fatty acyl-CoA ligases in Mycobacterium tuberculosis.结核分枝杆菌中酰基辅酶 A 连接酶和酰基辅酶 A 酰胺酶小分子抑制剂的开发。
Eur J Med Chem. 2020 Sep 1;201:112408. doi: 10.1016/j.ejmech.2020.112408. Epub 2020 Jun 13.
3
The Key Roles of FadD23 C-terminal Domain in Catalytic Mechanisms.FadD23 C末端结构域在催化机制中的关键作用
Front Microbiol. 2023 Feb 21;14:1090534. doi: 10.3389/fmicb.2023.1090534. eCollection 2023.
4
Structures of Mycobacterium tuberculosis FadD10 protein reveal a new type of adenylate-forming enzyme.结核分枝杆菌 FadD10 蛋白结构揭示了一种新型的腺嘌呤形成酶。
J Biol Chem. 2013 Jun 21;288(25):18473-83. doi: 10.1074/jbc.M113.466912. Epub 2013 Apr 26.
5
Mechanistic and functional insights into fatty acid activation in Mycobacterium tuberculosis.对结核分枝杆菌中脂肪酸激活的机制和功能洞察
Nat Chem Biol. 2009 Mar;5(3):166-73. doi: 10.1038/nchembio.143. Epub 2009 Feb 1.
6
Fatty acyl-AMP ligases and polyketide synthases are unique enzymes of lipid biosynthetic machinery in Mycobacterium tuberculosis.脂肪酸酰基-AMP 连接酶和聚酮合酶是结核分枝杆菌脂质生物合成机制中特有的酶。
Tuberculosis (Edinb). 2011 Sep;91(5):448-55. doi: 10.1016/j.tube.2011.04.006. Epub 2011 May 20.
7
Insight into Structure-Function Relationships and Inhibition of the Fatty Acyl-AMP Ligase (FadD32) Orthologs from Mycobacteria.深入了解分枝杆菌中脂肪酰基-AMP连接酶(FadD32)直系同源物的结构-功能关系及抑制作用。
J Biol Chem. 2016 Apr 8;291(15):7973-89. doi: 10.1074/jbc.M115.712612. Epub 2016 Feb 21.
8
Molecular basis of the functional divergence of fatty acyl-AMP ligase biosynthetic enzymes of Mycobacterium tuberculosis.结核分枝杆菌脂肪酸酰基辅酶 A 连接酶生物合成酶功能分化的分子基础。
J Mol Biol. 2012 Feb 17;416(2):221-38. doi: 10.1016/j.jmb.2011.12.031. Epub 2011 Dec 21.
9
Assay development for identifying inhibitors of the mycobacterial FadD32 activity.用于鉴定分枝杆菌FadD32活性抑制剂的检测方法开发。
J Biomol Screen. 2013 Jun;18(5):576-87. doi: 10.1177/1087057112474691. Epub 2013 Jan 30.
10
Structure of the Essential FadD32 Enzyme: A Promising Drug Target for Treating Tuberculosis.必需的FadD32酶的结构:一种有前景的治疗结核病的药物靶点。
ACS Infect Dis. 2016 Aug 12;2(8):579-591. doi: 10.1021/acsinfecdis.6b00082. Epub 2016 Jul 1.

本文引用的文献

1
The Key Roles of FadD23 C-terminal Domain in Catalytic Mechanisms.FadD23 C末端结构域在催化机制中的关键作用
Front Microbiol. 2023 Feb 21;14:1090534. doi: 10.3389/fmicb.2023.1090534. eCollection 2023.
2
Crystal structures of FadD32 and pks13-ACP domain from Corynebacterium diphtheriae. Corynebacterium diphtheriae 的 FadD32 和 pks13-ACP 结构域的晶体结构。
Biochem Biophys Res Commun. 2022 Jan 29;590:152-157. doi: 10.1016/j.bbrc.2021.12.083. Epub 2021 Dec 25.
3
Development of small-molecule inhibitors of fatty acyl-AMP and fatty acyl-CoA ligases in Mycobacterium tuberculosis.结核分枝杆菌中酰基辅酶 A 连接酶和酰基辅酶 A 酰胺酶小分子抑制剂的开发。
Eur J Med Chem. 2020 Sep 1;201:112408. doi: 10.1016/j.ejmech.2020.112408. Epub 2020 Jun 13.
4
Mycobacterium tuberculosis Sulfolipid-1 Activates Nociceptive Neurons and Induces Cough.结核分枝杆菌磺脂 1 激活伤害感受器神经元并诱发咳嗽。
Cell. 2020 Apr 16;181(2):293-305.e11. doi: 10.1016/j.cell.2020.02.026. Epub 2020 Mar 5.
5
Structure of the Essential FadD32 Enzyme: A Promising Drug Target for Treating Tuberculosis.必需的FadD32酶的结构:一种有前景的治疗结核病的药物靶点。
ACS Infect Dis. 2016 Aug 12;2(8):579-591. doi: 10.1021/acsinfecdis.6b00082. Epub 2016 Jul 1.
6
Insight into Structure-Function Relationships and Inhibition of the Fatty Acyl-AMP Ligase (FadD32) Orthologs from Mycobacteria.深入了解分枝杆菌中脂肪酰基-AMP连接酶(FadD32)直系同源物的结构-功能关系及抑制作用。
J Biol Chem. 2016 Apr 8;291(15):7973-89. doi: 10.1074/jbc.M115.712612. Epub 2016 Feb 21.
7
Crystal structure of FadD32, an enzyme essential for mycolic acid biosynthesis in mycobacteria.法迪32(FadD32)的晶体结构,一种在分枝杆菌中参与分枝菌酸生物合成的必需酶。
Sci Rep. 2015 Dec 2;5:15493. doi: 10.1038/srep15493.
8
Synthesis and structure-activity relationships of phenyl-substituted coumarins with anti-tubercular activity that target FadD32.苯取代香豆素类化合物的合成及抗结核活性与 FadD32 靶点的结构活性关系研究
Bioorg Med Chem Lett. 2013 Nov 15;23(22):6052-9. doi: 10.1016/j.bmcl.2013.09.035. Epub 2013 Sep 19.
9
Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32.二芳基乙烯基类化合物通过靶向 FadD32 抑制分枝菌酸生物合成并杀死结核分枝杆菌。
Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11565-70. doi: 10.1073/pnas.1302114110. Epub 2013 Jun 24.
10
Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis.抗结核噻吩类化合物定义了 Pks13 在分枝菌酸生物合成中的需求。
Nat Chem Biol. 2013 Aug;9(8):499-506. doi: 10.1038/nchembio.1277. Epub 2013 Jun 16.